Novavax execs cash out on stock buoyed by Covid-19 vaccine work By: Washington Business Journal via Business Journals August 21, 2020 at 15:11 PM EDT The sales follow recent developments in Novavax’s Covid-19 vaccine program that propelled its share price this year. Read More >> Related Stocks: Harbor Disruptive Innovation ETF